- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02179073
Health-related Quality of Life of Patients With Neurogenic Bladder
November 15, 2019 updated by: Swiss Paraplegic Centre Nottwil
Effects of Bladder Management on Health-related Quality of Life in Patients With Neurogenic Bladder
Bladder management has a major impact on the quality of life in patients with neurogenic bladder dysfunction.
This a prospective investigation of the effects of the method for bladder evacuation on the health-related quality of life in patients with neurogenic bladder dysfunction.
The changes in health-related quality of life over time (longitudinal investigation) and the differences between the different methods for bladder evacuation will be investigated.
Patients will be given a standardized and validated questionnaire annually for 10 years.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
87
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
LU
-
Nottwil, LU, Switzerland, 6207
- Swiss Paraplegic Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
individuals with neurogenic bladder dysfunction
Description
Inclusion Criteria:
- Individuals with neurogenic bladder dysfunction
Exclusion Criteria:
- Insufficient dexterity to fill in the questionnaire
- Insufficient proficiency in the German or French language
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
neurogenic bladder dysfunction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
quality of life
Time Frame: up to year 10
|
Qualiveen questionnaire
|
up to year 10
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
bladder evacuation method
Time Frame: year 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
|
method for bladder evacuation (i.e.
intermittent catheterization, condom urinal, reflex micturition, transurethral catheter, suprapubic catheter, sacral bladder stimulator, neuromodulation)
|
year 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
|
urinary tract infections
Time Frame: year 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
|
number of annual symptomatic urinary tract infections
|
year 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
|
patient characteristics
Time Frame: time 0
|
gender, age, type of neurogenic bladder dysfunction, duration of neurogenic bladder dysfunction
|
time 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2007
Primary Completion (Actual)
October 31, 2019
Study Completion (Actual)
November 14, 2019
Study Registration Dates
First Submitted
June 26, 2014
First Submitted That Met QC Criteria
June 30, 2014
First Posted (Estimate)
July 1, 2014
Study Record Updates
Last Update Posted (Actual)
November 18, 2019
Last Update Submitted That Met QC Criteria
November 15, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2007-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurogenic Bladder Dysfunction
-
Ulrich MehnertNCCR (National Center of Competence in Resaerch, Switzerland)CompletedHealthy | Neurogenic Bladder Dysfunction Nos | Nonneurogenic Neurogenic Bladder DysfunctionSwitzerland
-
Novartis PharmaceuticalsTerminatedNeurogenic Urinary Bladder | Neurogenic Bladder Disorder | Neurogenic Dysfunction of the Urinary Bladder | Neurogenic Bladder, Uninhibited | Neurogenic Bladder, SpasticNetherlands, Germany, Switzerland
-
University of ZurichTerminatedNeurogenic Bladder DysfunctionSwitzerland
-
APOGEPHA Arzneimittel GmbHCompletedUrologic Diseases | Urinary Incontinence | Urinary Bladder, Neurogenic | Neurogenic Urinary Bladder Disorder | Bladder Disorder, Neurogenic | Urinary Bladder Disorder, Neurogenic | Neurogenic Bladder Disorder | Urinary Bladder Neurogenic Dysfunction | Overactive Detrusor FunctionRomania, Austria, Germany
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingImmunosuppression | Neurogenic Bladder | Bladder DysfunctionUnited States
-
Coloplast A/SCompletedNeurogenic Bladder Dysfunction NosDenmark, France, Germany, Norway, Sweden
-
JW PharmaceuticalCompletedNeurogenic Bladder | Voiding DysfunctionKorea, Republic of
-
The Methodist Hospital Research InstituteCompleted
-
University of ZurichRecruitingNeurogenic Bladder DysfunctionBelgium, Brazil, Italy, Switzerland
-
Baylor College of MedicineU.S. Department of EducationTerminatedSpinal Cord Injury | Neurogenic Bladder Dysfunction NosUnited States